Good: Transplants for nonmalignant diseases generally have more favorable outcomes, with survival rate of 70-90% if the donor is a matched sibling and 36-65% if the donor is unrelated. Transplants for acute leukemias (eg, all, aml) in remission at the time of transplant have survival rates of 55-68% if the donor is related and 26-50% if the donor is unrelated.
Answered 2/1/2012
6.1k views
On match& indication: On cancers use autologous ( same person) bone marrow has excellent take , use of donor( allogenic ) in non cancer diseases like aplastic anemia , thalassemia, & immune system disorders , not as good as autologous due to nature of the disease.
Answered 12/9/2013
5.4k views
A doctor has provided 1 answer
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
2 doctors weighed in across 2 answers
6 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question